For more than 125 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to prevent and treat diseases that threaten people and animals — including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases — as we aspire to be the premier research-intensive biopharmaceutical company in the world.

Website
Health PolicyNovember 19, 2020
Embracing innovation to improve cancer outcomes
How do we harness innovation to restore cancer services through Covid-19 and beyond? This question found its way under the microscope at the Public Policy Projects Virtual Annual Conference 2020, bringing a panel of experts together to address it.

Become a Partner

If you would like to enquire about working with Public Policy Projects, please contact partnerships@publicpolicyprojects.com for more information.
Public Policy Projects
  • operations@publicpolicyprojects.com
  • 0207 8399305

ISSN Number: 2517-2662